MOMA-313 is under clinical development by Moma Therapeutics and currently in Phase I for Metastatic Prostate Cancer.

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

Alphaf-001 is under clinical development by Alpha Fusion and currently in Phase I for Papillary Thyroid Cancer.

A surprising discovery reveals that a gene previously thought to accelerate esophageal cancer actually helps protect against it initially. This pivotal study could lead to better prediction and ...

Since its discovery in the 1990s, "programmed cell death protein 1," or PD-1, has been regarded as a leading target in cancer treatments.

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

A genetic fault long believed to drive the development of esophageal cancer may in fact play a protective role early in the disease. This unexpected discovery could help doctors identify which ...

Drinking tea and coffee could have notable health benefits, going by analysis published in CANCER, an American Cancer Society ...

Scientists have discovered significant discrepancies in PD-1 between humans and rodents, indicating that common lab models ...

The discovery could help explain why some cancer patients respond well to certain treatments, while others are not so lucky.

Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain treatments, others might not be as fortunate. Doctors and scientists have long struggled to ...

Scientists found that healthy women can carry genetic changes in their breast cells that are thought to be characteristic of ...